|
34 Companies |
|
37 Products |
|
37 Products |
|
35 Mechanisms of Action |
|
2 Trials |
|
396 News |
|
| «12345678» |
- Enrollment change: Effectiveness of Ultrasound Combine TENS in Treatment of Upper Trapezius Myofascial Pain (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=40, Completed, Sponsor: Sirindhorn National Medical Rehabilitation Centre
N=80 --> 40
- Trial completion: Effectiveness of Ultrasound Combine TENS in Treatment of Upper Trapezius Myofascial Pain (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=40, Completed, Sponsor: Sirindhorn National Medical Rehabilitation Centre
N=80 --> 40 Recruiting --> Completed
- Trial completion: TCM-TMD: Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial (clinicaltrials.gov) - Jan 15, 2013
P2, N=160, Completed, Sponsor: University of Arizona
Recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion: D-Ribose for Fatigue in Subjects With Fibromyalgia (clinicaltrials.gov) - Jan 8, 2013
P2, N=110, Completed, Sponsor: RiboCor, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || New P3 trial: CAMMPS: Comprehensive vs. Assisted Management of Mood and Pain Symptoms (clinicaltrials.gov) - Dec 26, 2012
P3, N=300, Enrolling by invitation, Sponsor: Department of Veterans Affairs
- Trial withdrawal, HEOR: Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain (clinicaltrials.gov) - Dec 12, 2012
P2, N=0, Withdrawn, Sponsor: Stamford Hospital
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Enrollment change, HEOR: Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain (clinicaltrials.gov) - Dec 12, 2012
P2, N=0, Withdrawn, Sponsor: Stamford Hospital
Not yet recruiting --> Withdrawn N=60 --> 0
- New P1/2 trial: Effects of Direct Transcranial Current Stimulation on Central Neural Pain Processing in Fibromyalgia (clinicaltrials.gov) - Dec 5, 2012
P1/2, N=20, Recruiting, Sponsor: University of Michigan
- | quetiapine / Generic mfg.
Enrollment closed: Quetiapine Compared With Placebo in the Management of Fibromyalgia (clinicaltrials.gov) - Dec 3, 2012
P4, N=42, Active, not recruiting, Sponsor: East Tennessee State University
N=60 --> 0 Recruiting --> Active, not recruiting
- Trial completion, HEOR: Efficacy of Shiatsu in Individuals With Fibromyalgia: a Randomized Clinical Trial (clinicaltrials.gov) - Nov 13, 2012
P=N/A, N=34, Completed, Sponsor: University of Sao Paulo General Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Enrollment closed: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Oct 25, 2012
P2/3, N=111, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- New P2/3 trial: Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (clinicaltrials.gov) - Oct 11, 2012
P2/3, N=40, Recruiting, Sponsor: Chisel Peak Medical Clinic
- Zaditor (ketotifen) / Novartis
Enrollment closed: Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study (clinicaltrials.gov) - Oct 10, 2012
P3, N=46, Active, not recruiting, Sponsor: Indiana University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Savella (milnacipran) / AbbVie, Pierre Fabre
Trial completion: Drug and Talk Therapy for Fibromyalgia (clinicaltrials.gov) - Oct 10, 2012
P4, N=48, Completed, Sponsor: Indiana University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion: Physical Exercise and Its Impact on Signs of Inflammation in Fibromyalgia (clinicaltrials.gov) - Sep 27, 2012
P=N/A, N=67, Completed, Sponsor: G
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: The Pathogenesis of Idiopathic Dry Eyes (clinicaltrials.gov) - Sep 25, 2012
P=N/A, N=100, Recruiting, Sponsor: University of Michigan
Recruiting --> Completed Completed --> Recruiting
- | Enrollment change: Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders (clinicaltrials.gov) - Sep 11, 2012
P3, N=60, Completed, Sponsor: H
Completed --> Recruiting N=90 --> 60
- | Trial completion: Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders (clinicaltrials.gov) - Sep 11, 2012
P3, N=60, Completed, Sponsor: H
N=90 --> 60 Recruiting --> Completed
- Trial completion: D1P2-TMD: Conservative Treatment of Patients With Temporomandibular Disorders (clinicaltrials.gov) - Sep 5, 2012
P=N/A, N=80, Completed, Sponsor: Palmer College of Chiropractic
Recruiting --> Completed Active, not recruiting --> Completed
- Clinical: Prevalence of Signs and Symptoms of TMD in Patients Wearing Double Complete Dentures, RPD and in Dentistry Students. (clinicaltrials.gov) - Aug 31, 2012
P=N/A, N=210, Completed, Sponsor: Universidade Estadual do Oeste do Paraná
- Clinical: FMQEEG-10-26: Quantitative EEG During PSG in Patients With and Without Fibromyalgia (clinicaltrials.gov) - Aug 26, 2012
P=N/A, N=560, Active, not recruiting, Sponsor: SouthCoast Medical Group
- Clinical: The Effectiveness of Operant Learning Versus Energy Conservation Activity Pacing Treatments in Fibromyalgia (clinicaltrials.gov) - Aug 16, 2012
P=N/A, N=120, Not yet recruiting, Sponsor: Lawson Health Research Institute
- | Savella (milnacipran) / AbbVie, Pierre Fabre
Trial termination: Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (clinicaltrials.gov) - Aug 6, 2012
P2, N=57, Terminated, Sponsor: Forest Laboratories
Active, not recruiting --> Completed Active, not recruiting --> Terminated
- Savella (milnacipran) / AbbVie, Pierre Fabre
Enrollment change: Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (clinicaltrials.gov) - Aug 6, 2012
P2, N=57, Terminated, Sponsor: Forest Laboratories
Active, not recruiting --> Terminated N=200 --> 57
- Clinical: Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=116, Completed, Sponsor: Federal University of São Paulo
- Enrollment change: STIMALGI: Repetitive Transcranial Magnetic Stimulation in Fibromyalgia (clinicaltrials.gov) - Aug 1, 2012
P=N/A, N=42, Recruiting, Sponsor: University Hospital, Grenoble
N=200 --> 57 N=60 --> 42
- |||| pregabalin / Generic mfg.
Trial completion: Flexdose: Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia (clinicaltrials.gov) - Jul 29, 2012
P4, N=174, Completed, Sponsor: Osteoporosis Medical Center, Beverly Hills, CA
N=60 --> 42 Recruiting --> Completed
- mirtazapine / Generic mfg.
Enrollment change: Study of Indoleamine 2,3-dioxygenase Activity, Serum Levels of Cytokines, BDNF, BH4 and Mirtazapine Efficacy in Fibromyalgia Syndrome (clinicaltrials.gov) - Jul 23, 2012
P2, N=80, Completed, Sponsor: Mahidol University
Recruiting --> Completed N=216 --> 80
- || New P3 trial: Online Acceptance-based Behavioural Treatment for Fibromyalgia (clinicaltrials.gov) - Jul 15, 2012
P3, N=100, Active, not recruiting, Sponsor: University of Manitoba
- naltrexone / Generic mfg.
Trial withdrawal: Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Florida
N=216 --> 80 Recruiting --> Withdrawn
- naltrexone / Generic mfg.
Enrollment change: Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Florida
Recruiting --> Withdrawn N=80 --> 0
- Clinical: CuFib: Cupping in Fibromyalgia (clinicaltrials.gov) - Jul 5, 2012
P=N/A, N=141, Recruiting, Sponsor: Universität Duisburg-Essen
- etoricoxib / Generic mfg.
Trial termination: Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder (clinicaltrials.gov) - Jun 28, 2012
P3, N=45, Terminated, Sponsor: Clinica Virgen Milagrosa
N=80 --> 0 Not yet recruiting --> Terminated; Change in current areas of research interest of the collaborator
- etoricoxib / Generic mfg.
Trial initiation date: Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder (clinicaltrials.gov) - Jun 28, 2012
P3, N=45, Terminated, Sponsor: Clinica Virgen Milagrosa
Not yet recruiting --> Terminated; Change in current areas of research interest of the collaborator Initiation date: Aug 2009 --> Nov 2009
- etoricoxib / Generic mfg.
Enrollment change: Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder (clinicaltrials.gov) - Jun 28, 2012
P3, N=45, Terminated, Sponsor: Clinica Virgen Milagrosa
Initiation date: Aug 2009 --> Nov 2009 N=300 --> 45
- ||||| duloxetine / Generic mfg.
Enrollment closed: Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome (clinicaltrials.gov) - Jun 28, 2012
P2/3, N=60, Active, not recruiting, Sponsor: University of Cincinnati
N=300 --> 45 Recruiting --> Active, not recruiting
- || New P3 trial: Sophrodol-1: Efficacy Study of Relaxation to 12 Weeks Against Placebo in the Overall Care Chronic Pain in Patients With Fibromyalgia (clinicaltrials.gov) - Jun 25, 2012
P3, N=72, Recruiting, Sponsor: Centre Hospitalier Universitaire, Amiens
- |||||||||| duloxetine / Generic mfg.
New P3 trial: An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057) (clinicaltrials.gov) - Jun 14, 2012
P3, N=150, Completed, Sponsor: Eli Lilly and Company
- New P2 trial: Investigation of AVACEN Thermal Exchange System for Fibromyalgia Pain (clinicaltrials.gov) - Jun 12, 2012
P2, N=21, Completed, Sponsor: University of California, San Diego
- Enrollment change: Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia (clinicaltrials.gov) - Jun 11, 2012
P1/2, N=46, Completed, Sponsor: University of Michigan
Recruiting --> Active, not recruiting N=80 --> 46
- New P2/3 trial: Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (clinicaltrials.gov) - Jun 10, 2012
P2/3, N=42, Enrolling by invitation, Sponsor: Frusso, Ricardo, M.D.
- || New P3 trial: rTMS for the Treatment of Chronic Pain in GW1 Veterans (clinicaltrials.gov) - May 29, 2012
P3, N=206, Recruiting, Sponsor: Department of Veterans Affairs
- New P1 trial: Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program (clinicaltrials.gov) - May 13, 2012
P1, N=135, Completed, Sponsor: North York General Hospital
- Clinical: Acute Effects of Exercise in Women With Fibromyalgia (FM) (clinicaltrials.gov) - May 3, 2012
P=N/A, N=60, Recruiting, Sponsor: Göteborg University
- || Enrollment change: A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia (clinicaltrials.gov) - May 1, 2012
P=N/A, N=57, Completed, Sponsor: Mayo Clinic
N=80 --> 46 N=30 --> 57
- ||| Trial completion: A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia (clinicaltrials.gov) - May 1, 2012
P=N/A, N=57, Completed, Sponsor: Mayo Clinic
N=30 --> 57 Active, not recruiting --> Completed
- nifedipine immediate release / Generic mfg.
Trial initiation date: A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain (clinicaltrials.gov) - Apr 23, 2012
P=N/A, N=68, Active, not recruiting, Sponsor: Vanderbilt University
Active, not recruiting --> Completed Initiation date: Apr 2012 --> Jul 2012
- Trial completion: Health Promotion for Women With Fibromyalgia (clinicaltrials.gov) - Apr 23, 2012
P=N/A, N=177, Completed, Sponsor: University of Texas at Austin
Initiation date: Apr 2012 --> Jul 2012 Active, not recruiting --> Completed
- Enrollment open: Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx) (clinicaltrials.gov) - Apr 19, 2012
P=N/A, N=216, Recruiting, Sponsor: Tufts Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| desvenlafaxine extended release / Generic mfg.
Enrollment change: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women (clinicaltrials.gov) - Apr 8, 2012
P3, N=381, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Not yet recruiting --> Recruiting N=300 --> 381